companydata.dkcompanydata.dk

ORIFARM PROPERTY A/S: Financial statements 2020

CVR: 27347266

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

ORIFARM PROPERTY A/S (CVR 27347266) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 12,250,000 and a net result of DKK 7,429,000 compared with DKK 7,393,000 the year before. That is an increase of 5.3% compared with the year before. Equity in the 2020 report amounted to DKK 72,643,000. The solvency ratio was 36.8%.

Gross Profit
DKK 12,250,000
Profit/Loss
DKK 7,429,000
Equity
DKK 72,643,000
Total Assets
DKK 197,465,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-12.3M7.4M72.6M-
2019-11.6M7.4M65.2M-
2018-11.7M7.5M57.8M-
2017-12.3M8.1M55.3M-
2016-12.3M8.2M62.3M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is ORIFARM PROPERTY A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Erik Sandberg joins the board of ORIFARM PROPERTY A/SJun 29, 2020

As of June 29, 2020, Erik Sandberg has joined the board of directors of ORIFARM PROPERTY A/S.

Lars Monrad-Gylling leaves the board of ORIFARM PROPERTY A/SJun 29, 2020

As of June 29, 2020, Lars Monrad-Gylling has left the board of directors of ORIFARM PROPERTY A/S.

ORIFARM PROPERTY A/S: The 2019 annual report is outJun 25, 2020

ORIFARM PROPERTY A/S has published its annual report for 2019. Gross profit came to DKK 11,628,000, and the net result was DKK 7,393,000.

About ORIFARM PROPERTY A/S

ORIFARM PROPERTY A/S is a Danish company of the type Aktieselskab based in Odense S, founded in 2003. The company is registered under the industry Udlejning af erhvervsejendomme. The company was previously named EJENDOMSSELSKABET ENERGIVEJ 15 A/S. The management consists of Hans Carl Bøgh-Sørensen. The board consists of Mads Fink Eriksen (chair), Birgitte Bøgh-Sørensen, Hans Carl Bøgh-Sørensen and Nicki Lund Kristensen. The company is owned by ORIFARM GROUP A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 32,038,000 and a net result of DKK -1,684,000 compared with DKK -9,874,000 the year before. Equity in the 2025 report amounted to DKK 50,102,000.

Source: annual report 2025, Danish Business Authority